CSPHF
Price
$1.00
Change
+$0.14 (+16.28%)
Updated
Sep 23 closing price
Capitalization
1.26B
Intraday Buy/Sell Signals
IRON
Price
$73.01
Change
+$1.05 (+1.46%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
2.54B
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CSPHF vs IRON

Header iconCSPHF vs IRON Comparison
Open Charts CSPHF vs IRONBanner chart's image
CSTONE PHARMACEUTICALS
Price$1.00
Change+$0.14 (+16.28%)
Volume$150
Capitalization1.26B
Disc Medicine
Price$73.01
Change+$1.05 (+1.46%)
Volume$6.17K
Capitalization2.54B
CSPHF vs IRON Comparison Chart in %
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPHF vs. IRON commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Buy and IRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (CSPHF: $1.00 vs. IRON: $71.96)
Brand notoriety: CSPHF and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 5% vs. IRON: 122%
Market capitalization -- CSPHF: $1.34B vs. IRON: $2.5B
CSPHF [@Biotechnology] is valued at $1.34B. IRON’s [@Biotechnology] market capitalization is $2.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than CSPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPHF’s TA Score shows that 1 TA indicator(s) are bullish while IRON’s TA Score has 4 bullish TA indicator(s).

  • CSPHF’s TA Score: 1 bullish, 1 bearish.
  • IRON’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IRON is a better buy in the short-term than CSPHF.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while IRON (@Biotechnology) price change was +3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.86%. For the same industry, the average monthly price growth was +14.21%, and the average quarterly price growth was +268.76%.

Reported Earning Dates

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.54B) has a higher market cap than CSPHF($1.26B). CSPHF YTD gains are higher at: 343.459 vs. IRON (15.158).
CSPHFIRONCSPHF / IRON
Capitalization1.26B2.54B50%
EBITDAN/A-142.42M-
Gain YTD343.45915.1582,266%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A650M-
Total DebtN/A30.9M-
TECHNICAL ANALYSIS
Technical Analysis
CSPHFIRON
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
48%
Bearish Trend 7 days ago
76%
Momentum
ODDS (%)
N/A
Bullish Trend 7 days ago
84%
MACD
ODDS (%)
Bearish Trend 7 days ago
29%
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
35%
Bullish Trend 7 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
35%
Bullish Trend 7 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 7 days ago
76%
Aroon
ODDS (%)
N/A
Bullish Trend 7 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIGFX32.56N/A
N/A
Baron International Growth Retail
VMGAX800.05N/A
N/A
Vanguard Mega Cap Growth Index Instl
PYVAX17.23N/A
N/A
Payden Equity Income Adviser
AGCLX20.16N/A
N/A
American Century Global Small Cap A
FTXCX49.90N/A
N/A
FullerThaler Behavioral Sm-Cp Gr C

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
KMSTF - CSPHF
35%
Loosely correlated
N/A
IRON - CSPHF
32%
Poorly correlated
+1.46%
PHGE - CSPHF
21%
Poorly correlated
+2.79%
ZYME - CSPHF
21%
Poorly correlated
+0.66%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+1.46%
SYRE - IRON
55%
Loosely correlated
+10.86%
NUVL - IRON
55%
Loosely correlated
-5.66%
XNCR - IRON
52%
Loosely correlated
-11.03%
CGON - IRON
51%
Loosely correlated
-0.28%
IDYA - IRON
51%
Loosely correlated
+0.97%
More